Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention

  Chronic Heart Failure

  Free Subscription


1 Am Heart J
2 Am J Cardiol
3 Basic Res Cardiol
5 Circ Heart Fail
3 Circ Res
2 Circulation
1 Clin Cardiol
3 Eur Heart J
4 Eur J Heart Fail
1 Heart
5 Int J Cardiol
1 J Am Coll Cardiol
3 J Card Fail
3 J Cardiovasc Pharmacol
3 PLoS One

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Am Heart J

  1. HILL JA
    Ambulatory inotropic therapy: To what end?
    Am Heart J. 2022;248:170-171.

    Am J Cardiol

  2. CHIU L, Jairam MP, Chow R, Chiu N, et al
    Meta-Analysis of Point-of-Care Lung Ultrasonography Versus Chest Radiography in Adults With Symptoms of Acute Decompensated Heart Failure.
    Am J Cardiol. 2022 Apr 30. pii: S0002-9149(22)00334.
    PubMed         Abstract available

  3. AHMED A, Shahid I, Siddiqi AK, Ellahi A, et al
    Meta-Analysis of Novel Glucose-Lowering Agents in Patients With Type 2 Diabetes Mellitus Without Pre-existing Heart Failure.
    Am J Cardiol. 2022 Apr 30. pii: S0002-9149(22)00362.

    Basic Res Cardiol

  4. LEVAY MK, Krobert KA, Vogt A, Ahmad A, et al
    RGS3L allows for an M2 muscarinic receptor-mediated RhoA-dependent inotropy in cardiomyocytes.
    Basic Res Cardiol. 2022;117:8.
    PubMed         Abstract available

  5. HAUPT LP, Rebs S, Maurer W, Hubscher D, et al
    Doxorubicin induces cardiotoxicity in a pluripotent stem cell model of aggressive B cell lymphoma cancer patients.
    Basic Res Cardiol. 2022;117:13.
    PubMed         Abstract available

  6. COSTA A, Cushman S, Haubner BJ, Derda AA, et al
    Neonatal injury models: integral tools to decipher the molecular basis of cardiac regeneration.
    Basic Res Cardiol. 2022;117:26.
    PubMed         Abstract available

    Circ Heart Fail

  7. SINHA SS, Rosner CM, Tehrani BN, Maini A, et al
    Cardiogenic Shock From Heart Failure Versus Acute Myocardial Infarction: Clinical Characteristics, Hospital Course, and 1-Year Outcomes.
    Circ Heart Fail. 2022 May 5:101161CIRCHEARTFAILURE121009279.
    PubMed         Abstract available

  8. HE H, Baka T, Balschi J, Motani AS, et al
    Novel Small-Molecule Troponin Activator Increases Cardiac Contractile Function Without Negative Impact on Energetics.
    Circ Heart Fail. 2022;15:e009195.
    PubMed         Abstract available

  9. AGGARWAL R, Vaduganathan M, Chiu N, Bhatt DL, et al
    Out-of-Pocket Costs for SGLT-2 (Sodium-Glucose Transport Protein-2) Inhibitors in the United States.
    Circ Heart Fail. 2022;15:e009099.

    Peripheral Venous Pressure: An Important but Neglected Contributor to Echocardiographic Estimation of Pulmonary Artery Pressure With Exercise.
    Circ Heart Fail. 2022 Feb 22:CIRCHEARTFAILURE121009383.

  11. JORDA P, Martinez D, Farrero M, Marcos MA, et al
    BAG3 Genetic Cardiomyopathy May Overlap Fulminant Myocarditis Clinical Findings.
    Circ Heart Fail. 2022;15:e008443.

    Circ Res

  12. BOUCHERAT O, Agrawal V, Lawrie A, Bonnet S, et al
    The Latest in Animal Models of Pulmonary Hypertension and Right Ventricular Failure.
    Circ Res. 2022;130:1466-1486.
    PubMed         Abstract available

  13. ALENEZI F, Covington TA, Mukherjee M, Mathai SC, et al
    Novel Approaches to Imaging the Pulmonary Vasculature and Right Heart.
    Circ Res. 2022;130:1445-1465.
    PubMed         Abstract available

  14. HUSTON JH, Shah SJ
    Understanding the Pathobiology of Pulmonary Hypertension Due to Left Heart Disease.
    Circ Res. 2022;130:1382-1403.
    PubMed         Abstract available


  15. Correction to: 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
    Circulation. 2022;145:e1033.

    Border Disputes Between Heart Failure Phenotypes.
    Circulation. 2022;145:1374-1376.

    Clin Cardiol

  17. GUERRA F, D'Onofrio A, De Ruvo E, Manzo M, et al
    Decongestive treatment adjustments in heart failure patients remotely monitored with a multiparametric implantable defibrillators algorithm.
    Clin Cardiol. 2022 May 3. doi: 10.1002/clc.23832.
    PubMed         Abstract available

    Eur Heart J

    Heart and kidney: towards an integrated approach to secondary mitral regurgitation.
    Eur Heart J. 2022 Feb 18. pii: 6530471. doi: 10.1093.

  19. COWIE MR, Cleland JGF
    The COVID-19 pandemic and heart failure: lessons from GUIDE-HF.
    Eur Heart J. 2022 May 2. pii: 6576548. doi: 10.1093.

  20. LINDE C
    CRT-P or CRT-D in heart failure patients: the RESET-CRT project-a prelude to the randomized controlled RESET-CRT study.
    Eur Heart J. 2022 May 3. pii: 6577069. doi: 10.1093.

    Eur J Heart Fail

  21. AIMO A, Vergaro G, Gonzalez A, Barison A, et al
    Cardiac Remodelling Part 2: Clinical, Imaging and Laboratory Findings A review from the Biomarkers Working Group of the Heart Failure Association of the ESC.
    Eur J Heart Fail. 2022 Apr 30. doi: 10.1002/ejhf.2522.
    PubMed         Abstract available

  22. ERQOU S, Adler AI, Challa AA, Fonarow GC, et al
    Insulin Resistance and Incident Heart Failure: A Meta-Analysis.
    Eur J Heart Fail. 2022 May 3. doi: 10.1002/ejhf.2531.

  23. SCHRAGE B, Lund LH, Benson L, Dahlstrom U, et al
    Predictors of primary prevention implantable cardioverter defibrillator use in heart failure with reduced ejection fraction: Impact of the predicted risk of sudden cardiac death and all-cause mortality.
    Eur J Heart Fail. 2022 May 3. doi: 10.1002/ejhf.2530.
    PubMed         Abstract available

  24. BOHBOT Y, Habib G, Laroche C, Stohr E, et al
    Characteristics, management, and outcomes of patients with left-sided infective endocarditis complicated by heart failure: A substudy of the ESC-EORP EURO-ENDO (European infective endocarditis) registry.
    Eur J Heart Fail. 2022 May 4. doi: 10.1002/ejhf.2525.
    PubMed         Abstract available


  25. Correction: Heart failure medication dosage and survival in women and men seen at outpatient clinics.
    Heart. 2022 May 5. pii: heartjnl-2021-319229.

    Int J Cardiol

  26. QIAN Z, Qin C, Zou F, Xue S, et al
    Complete electrical reverse remodeling of native conduction after resynchronization therapies.
    Int J Cardiol. 2022;357:81-87.
    PubMed         Abstract available

  27. BASIC C, Rosengren A, Dahlstrom U, Edner M, et al
    Sex-related differences among young adults with heart failure in Sweden.
    Int J Cardiol. 2022 Apr 28. pii: S0167-5273(22)00635.
    PubMed         Abstract available

  28. FRIGELLI M, Sturla F, Milani V, Ramputi L, et al
    Prognostic value of left atrial strain quantification from 2D ultrasound imaging in post-ischemic heart failure patients: evidence from the REMODEL-HF study.
    Int J Cardiol. 2022 Apr 30. pii: S0167-5273(22)00633.
    PubMed         Abstract available

  29. IMRAN TF, Mohebali D, Lopez D, Goli RR, et al
    NT-proBNP and predictors of event free survival and left ventricular systolic function recovery in peripartum cardiomyopathy.
    Int J Cardiol. 2022;357:48-54.
    PubMed         Abstract available

  30. SEIDEL F, Opgen-Rhein B, Rentzsch A, Boehne M, et al
    Clinical characteristics and outcome of biopsy-proven myocarditis in children - Results of the German prospective multicentre registry "MYKKE".
    Int J Cardiol. 2022;357:95-104.
    PubMed         Abstract available

    J Am Coll Cardiol

  31. FUDIM M, Kaye DM, Borlaug BA, Shah SJ, et al
    Venous Tone and Stressed Blood Volume in Heart Failure: JACC Review Topic of the Week.
    J Am Coll Cardiol. 2022;79:1858-1869.
    PubMed         Abstract available

    J Card Fail

  32. RALI AS, Ranka S, Mazurek JA, Brinkley MD, et al
    Exception-Status Listing: A Critical Pathway to Heart Transplantation for Adults With Congenital Heart Diseases.
    J Card Fail. 2022;28:415-421.
    PubMed         Abstract available

  33. CONIGLIO AC, Patel CB, Kittleson M, Schlendorf K, et al
    Innovations in Heart Transplantation: A Review.
    J Card Fail. 2022;28:467-476.
    PubMed         Abstract available

  34. KOZLITINA J, Garg S, Drazner MH, Matulevicius SA, et al
    Clinical Implications of the Amyloidogenic V122I Transthyretin Variant in the General Population.
    J Card Fail. 2022;28:403-414.
    PubMed         Abstract available

    J Cardiovasc Pharmacol

  35. ZHENG RJ, Wang Y, Tang JN, Duan JY, et al
    Association of SGLT2 inhibitors with risk of atrial fibrillation and stroke in patients with and without type 2 diabetes: a systemic review and meta-analysis of randomized controlled trials.
    J Cardiovasc Pharmacol. 2021 Nov 22. pii: 00005344-900000000-98109.
    PubMed         Abstract available

  36. MARCUSOHN E, Borreda I, Hellman Y, Habib M, et al
    IV Sodium Ferric Gluconate Complex in Patients with Iron Deficiency hospitalized due to Acute Heart Failure- Investigator initiated, Randomized controlled trial.
    J Cardiovasc Pharmacol. 2022 Apr 29. pii: 00005344-990000000-00038.
    PubMed         Abstract available

  37. CUI X, Wang Z, Dong X, Cheng Z, et al
    Comparative effectiveness and safety of milrinone and levosimendan as initial inotrope therapy in acute heart failure patients with renal dysfunction.
    J Cardiovasc Pharmacol. 2022 Mar 4. pii: 00005344-990000000-00031.
    PubMed         Abstract available

    PLoS One

  38. ANDERSON KM, Murphy D, Groninger H, Kolm P, et al
    Perceived symptoms as the primary indicators for 30-day heart failure readmission.
    PLoS One. 2022;17:e0267820.
    PubMed         Abstract available

  39. YAMAMOTO E, Kato T, Yaku H, Morimoto T, et al
    Appetite loss at discharge from acute decompensated heart failure: Observation from KCHF registry.
    PLoS One. 2022;17:e0267327.
    PubMed         Abstract available

  40. RIMBAS RC, Visoiu IS, Magda SL, Mihaila-Baldea S, et al
    New insights into the potential utility of the left atrial function analysis in heart failure with preserved ejection fraction diagnosis.
    PLoS One. 2022;17:e0267962.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Chronic Heart Failure is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.